![N-((1-Methylpiperidin-4-yl)methyl)-3-(3-(trifluoromethoxy)phenyl)imidazo[1,2-b]pyridazin-6-amine](https://static.cymitquimica.com/products/3D/img/FM43363.png "Clique para ampliar")
N-((1-Methylpiperidin-4-yl)methyl)-3-(3-(trifluoromethoxy)phenyl)imidazo[1,2-b]pyridazin-6-amine
CAS: 1025065-69-3
Ref. 3D-FM43363
| 1mg | A consultar | |
| 2mg | A consultar | |
| 5mg | A consultar | |
| 10mg | A consultar | |
| 25mg | A consultar |
Informação sobre produto
- N-[(1-Methyl-4-piperidinyl)methyl]-3-[3-(trifluoromethoxy)phenyl]imidazo[1,2-b]pyridazin-6-amine sulfate
N-((1-Methylpiperidin-4-yl)methyl)-3-(3-(trifluoromethoxy)phenyl)imidazo[1,2-b]pyridazin-6-amine (NCTA) is a novel anticancer drug that has been shown to be effective against cancer cells in vitro and in vivo. NCTA inhibits the transcriptional activation of cyclin D2, which is essential for the growth and survival of cancer cells. It also inhibits osteoclast formation, which leads to decreased bone resorption. NCTA has not yet been tested in humans but its clinical relevance has been demonstrated in animal models. The drug's protein target is pim-1, a protein that regulates cell migration and proliferation.
Propriedades químicas
Consulta técnica sobre: 3D-FM43363 N-((1-Methylpiperidin-4-yl)methyl)-3-(3-(trifluoromethoxy)phenyl)imidazo[1,2-b]pyridazin-6-amine
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
